Drawing for LUMINIS HEALTH

USPTO serial 88596471

LUMINIS HEALTH

Reviewed by CopyMark Law Group

Reg. 6420637Status 702Renewal
Filing date
Status date
Registration date
Jul 13, 2021
Examiner
CARLYLE, SHAUNIA P
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with LUMINIS HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Simor L. Moskowitz

Simor L. Moskowitz WESTERMAN HATTORI, LLP8500 Leesburg Pike, Ste. 7500Tysons, VA 22182United States

Goods and services

ClassDescriptionStatusFirst use
044medical clinic services; emergency medical services; urgent medical care services; healthcare services; healthcare services, namely, wellness and health-related consulting services; healthcare services, namely, maternity care services; pain management services; medical services, namely, surgery; clinical mental health counseling services; physical therapy; rehabilitation patient care services; medical radiology services; medical diagnostic imaging, monitoring and reporting; medical clinic providing weight loss counseling and solutions; medical testing for diagnostic or treatment purposes; providing information and counseling in the field of diabetes; obstetrics and gynecology services; medical services in the field of neurology; speech pathology therapy services; addiction treatment services; occupational therapy services; ophthalmology services; healthcare services, namely, maternity care services; blood bank services; medical services, namely, joint replacement; healthcare services, namely, wellness programs; medical services in the field of oncology, neurology, cardiology, endocrinology, gastroenterology. orthopedics and sports medicine, and pediatrics and bariatrics; medical services, namely, the treatment and prevention of arthritis; medical services, namely, the treatment of hands and fingers; medical services, namely, the treatment of hands and fingers; medical services, namely, back and neck pain treatment; medical services, namely, outpatient procedures for the treatment of back and neck pain and for spine care; medical services; medical consultation and advice services provided by means of a telephone hotline; addiction treatment services; inpatient and outpatient healthcare for teens and adults who suffer from drug and alcohol use, and patients who suffer from a combination of substance use and mental health problems; rehabilitation patient care services which includes inpatient and outpatient care; providing psychological counseling to individuals who have been charged with a DUI or DWI offenseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 2, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 2, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 20, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Jul 13, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 13, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 8, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 7, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 29, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 27, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 17, 2021IUAFUSE AMENDMENT FILED—
May 17, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 26, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 26, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 22, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 27, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 27, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 7, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 4, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 4, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jun 14, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 14, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Jun 14, 2020CNSLSUSPENSION LETTER WRITTEN—
May 30, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 29, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 5, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 2, 2019DOCKASSIGNED TO EXAMINER—
Oct 29, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Oct 23, 2019ALIEASSIGNED TO LIE—
Oct 17, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance